186 related articles for article (PubMed ID: 25819079)
1. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
Amgalan B; Lee H
Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
[TBL] [Abstract][Full Text] [Related]
2. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
3. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
4. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
6. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
Park H; Niida A; Imoto S; Miyano S
J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
[TBL] [Abstract][Full Text] [Related]
7. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
8. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Baur B; Bozdag S
Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487
[TBL] [Abstract][Full Text] [Related]
9. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
10. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
11. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
Wei PJ; Zhang D; Xia J; Zheng CH
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
[TBL] [Abstract][Full Text] [Related]
12. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
13. MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples.
Trifonov V; Pasqualucci L; Dalla Favera R; Rabadan R
BMC Syst Biol; 2013 Mar; 7():25. PubMed ID: 23531283
[TBL] [Abstract][Full Text] [Related]
14. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.
Ping Y; Deng Y; Wang L; Zhang H; Zhang Y; Xu C; Zhao H; Fan H; Yu F; Xiao Y; Li X
Nucleic Acids Res; 2015 Feb; 43(4):1997-2007. PubMed ID: 25653168
[TBL] [Abstract][Full Text] [Related]
15. Uncovering driver genes in breast cancer through an innovative machine learning mutational analysis method.
Taheri G; Habibi M
Comput Biol Med; 2024 Mar; 171():108234. PubMed ID: 38430742
[TBL] [Abstract][Full Text] [Related]
16. Inferring causal genomic alterations in breast cancer using gene expression data.
Tran LM; Zhang B; Zhang Z; Zhang C; Xie T; Lamb JR; Dai H; Schadt EE; Zhu J
BMC Syst Biol; 2011 Aug; 5():121. PubMed ID: 21806811
[TBL] [Abstract][Full Text] [Related]
17. A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
Mahmood SF; Gruel N; Chapeaublanc E; Lescure A; Jones T; Reyal F; Vincent-Salomon A; Raynal V; Pierron G; Perez F; Camonis J; Del Nery E; Delattre O; Radvanyi F; Bernard-Pierrot I
Carcinogenesis; 2014 Mar; 35(3):670-82. PubMed ID: 24148822
[TBL] [Abstract][Full Text] [Related]
18. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
19. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
Wang L; Li F; Sheng J; Wong ST
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
Ohshima K; Hatakeyama K; Nagashima T; Watanabe Y; Kanto K; Doi Y; Ide T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Serizawa M; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Sci Rep; 2017 Apr; 7(1):641. PubMed ID: 28377632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
